Jazz Pharmaceuticals (JAZZ) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-8.25
-2.79
2.67
8.13

Details

Expected EPS
5.946454
Actual EPS
8.13
Surprise EPS
2.18
Surprise Percent
+36.72%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 8.13 per share for Q4 2025.

0 Comments

Share your thoughts